46 related articles for article (PubMed ID: 25060751)
1. Strategies for recruitment of relatives of BRCA mutation carriers to a genetic testing program in the Bahamas.
Trottier M; Lunn J; Butler R; Curling D; Turnquest T; Royer R; Akbari MR; Donenberg T; Hurley J; Narod SA
Clin Genet; 2015 Aug; 88(2):182-6. PubMed ID: 25060751
[TBL] [Abstract][Full Text] [Related]
2. Predictors of Women's Intentions to Communicate Updated Genetic Test Results to Immediate and Extended Family Members.
Winskill C; Goodman MS; Daly BM; Elrick A; Mooney R; Espinel W; Kohlmann W; Kaphingst KA
Public Health Genomics; 2023; 26(1):24-34. PubMed ID: 36642066
[TBL] [Abstract][Full Text] [Related]
3. Scarlatina in the Bahamas: Supposed Latency of the Disease for Eleven Weeks.
Duncome F
Med Exam (Phila); 1846 May; 2(17):327. PubMed ID: 38120177
[No Abstract] [Full Text] [Related]
4. Prevalence of founder mutations in the BRCA1 and BRCA2 genes among unaffected women from the Bahamas.
Trottier M; Lunn J; Butler R; Curling D; Turnquest T; Francis W; Halliday D; Royer R; Zhang S; Li S; Thompson I; Donenberg T; Hurley J; Akbari MR; Narod SA
Clin Genet; 2016 Mar; 89(3):328-31. PubMed ID: 25920394
[TBL] [Abstract][Full Text] [Related]
5. Cancer Risk Awareness and Concern among Women with a Family History of Breast or Ovarian Cancer.
Andersen MR; Thorpe J; Buist DS; Beatty JD; Watabayashi K; Hanson N; Resta R; Chubak J; Urban N
Behav Med; 2016; 42(1):18-28. PubMed ID: 25062114
[TBL] [Abstract][Full Text] [Related]
6. Expanding access to genetic testing for pancreatic cancer.
Rodriguez NJ; Syngal S
Fam Cancer; 2024 May; ():. PubMed ID: 38733419
[TBL] [Abstract][Full Text] [Related]
7. Psychosocial barriers and facilitators for cascade genetic testing in hereditary breast and ovarian cancer: a scoping review.
Afaya A; Kim SW; Park HS; Lim MC; Jung MS; Nam EJ; Park JS; Jeong J; Ryu JM; Kim J; Kim J; Kim M; Jin J; Han J; Kim SY; Park SY; Katapodi MC; Kim S;
Fam Cancer; 2024 Apr; ():. PubMed ID: 38662264
[TBL] [Abstract][Full Text] [Related]
8. Choices for cancer prevention for women with a BRCA1 mutation? a personal view.
Narod SA
Hered Cancer Clin Pract; 2023 Nov; 21(1):26. PubMed ID: 38031144
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of disparities in perceived healthcare discrimination among
Dibble KE; Connor AE
Women Health; 2023 Aug; 63(7):539-550. PubMed ID: 37461380
[TBL] [Abstract][Full Text] [Related]
10. Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-Analysis.
Frey MK; Ahsan MD; Bergeron H; Lin J; Li X; Fowlkes RK; Narayan P; Nitecki R; Rauh-Hain JA; Moss HA; Baltich Nelson B; Thomas C; Christos PJ; Hamilton JG; Chapman-Davis E; Cantillo E; Holcomb K; Kurian AW; Lipkin S; Offit K; Sharaf RN
J Clin Oncol; 2022 Dec; 40(35):4129-4143. PubMed ID: 35960887
[TBL] [Abstract][Full Text] [Related]
11. Anxiety and depression among racial/ethnic minorities and impoverished women testing positive for BRCA1/2 mutations in the United States.
Dibble KE; Connor AE
Support Care Cancer; 2022 Jul; 30(7):5769-5778. PubMed ID: 35344102
[TBL] [Abstract][Full Text] [Related]
12. Residential Locale Is Associated with Disparities in Genetic Testing-Related Outcomes Among BRCA1/2-Positive Women.
Dibble KE; Connor AE
J Racial Ethn Health Disparities; 2023 Apr; 10(2):718-729. PubMed ID: 35178668
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 experiences predicting high anxiety and depression among a sample of BRCA1/BRCA2-positive women in the US.
Dibble KE; Connor AE
Sci Rep; 2021 Dec; 11(1):24501. PubMed ID: 34969949
[TBL] [Abstract][Full Text] [Related]
14. IMProving care After inherited Cancer Testing (IMPACT) study: protocol of a randomized trial evaluating the efficacy of two interventions designed to improve cancer risk management and family communication of genetic test results.
Cragun D; Beckstead J; Farmer M; Hooker G; Dean M; Matloff E; Reid S; Tezak A; Weidner A; Whisenant JG; Pal T
BMC Cancer; 2021 Oct; 21(1):1099. PubMed ID: 34645413
[TBL] [Abstract][Full Text] [Related]
15. Breast Cancer in the Caribbean.
Samaroo K; Hosein A; Olivier LK; Ali J
Cureus; 2021 Aug; 13(8):e17042. PubMed ID: 34522520
[TBL] [Abstract][Full Text] [Related]
16. Gene Sequencing for Pathogenic Variants Among Adults With Breast and Ovarian Cancer in the Caribbean.
George SHL; Donenberg T; Alexis C; DeGennaro V; Dyer H; Yin S; Ali J; Butler R; Chin SN; Curling D; Lowe D; Lunn J; Turnquest T; Wharfe G; Cerbon D; Barreto-Coelho P; Schlumbrecht MP; Akbari MR; Narod SA; Hurley JE
JAMA Netw Open; 2021 Mar; 4(3):e210307. PubMed ID: 33646313
[TBL] [Abstract][Full Text] [Related]
17. Female family members lack understanding of indeterminate negative BRCA1/2 test results shared by probands.
Himes DO; Gibbons DK; Birmingham WC; Beckstrand RL; Gammon A; Kinney AY; Clayton MF
J Genet Couns; 2019 Oct; 28(5):950-961. PubMed ID: 31199558
[TBL] [Abstract][Full Text] [Related]
18. Breast Cancer Research in the Caribbean: Analysis of Reports From 1975 to 2017.
Ragin C; Banydeen R; Zhang C; Ben A; Calabrese V; Villa NN; Reville J; Dasgupta S; Bandyopadhyay M; Louden D; Dasgupta S
J Glob Oncol; 2018 Nov; 4():1-21. PubMed ID: 30481085
[TBL] [Abstract][Full Text] [Related]
19. Short report: Follow-up of Bahamian women with a BRCA1 or BRCA2 mutation.
Narod SA; Butler R; Bobrowski D; Akbari MR; Curling D; Lunn J; Ho C; Panahi S; Llacuachaqui M; Donenberg T; Hurley J
Mol Genet Genomic Med; 2018 Mar; 6(2):301-304. PubMed ID: 29266833
[TBL] [Abstract][Full Text] [Related]
20. Care delivery considerations for widespread and equitable implementation of inherited cancer predisposition testing.
Cragun D; Kinney AY; Pal T
Expert Rev Mol Diagn; 2017 Jan; 17(1):57-70. PubMed ID: 27910721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
